Zan Tang1,2, Junxiao Gao1, Jie Wu2, Guifang Zeng2, Yan Liao2, Zhenkun Song2, Xiao Liang2, Junyuan Hu2, Yong Hu3, Muyun Liu4, Nan Li5. 1. Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China. 2. Shenzhen Beike Biotechnology Co., Ltd., Shenzhen, Guangdong, China. 3. Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China. yong.hu@siat.ac.cn. 4. National-Local Associated Engineering Laboratory for Personalized Cell Therapy, Shenzhen, Guangdong, China. liumuyun@nlelpct.com. 5. Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China. nan.li@siat.ac.cn.
Abstract
BACKGROUND: Pulmonary fibrosis (PF) is a growing clinical problem with limited therapeutic options. Human umbilical cord mesenchymal stromal cell (hucMSC) therapy is being investigated in clinical trials for the treatment of PF patients. However, little is known about the underlying molecular and cellular mechanisms of hucMSC therapy on PF. In this study, the molecular and cellular behavior of hucMSC was investigated in a bleomycin-induced mouse PF model. METHODS: The effect of hucMSCs on mouse lung regeneration was determined by detecting Ki67 expression and EdU incorporation in alveolar type 2 (AT2) and lung fibroblast cells. hucMSCs were transfected to express the membrane localized GFP before transplant into the mouse lung. The cellular behavior of hucMSCs in mouse lung was tracked by GFP staining. Single cell RNA sequencing was performed to investigate the effects of hucMSCs on gene expression profiles of macrophages after bleomycin treatment. RESULTS: hucMSCs could alleviate collagen accumulation in lung and decrease the mortality of mouse induced by bleomycin. hucMSC transplantation promoted AT2 cell proliferation and inhibited lung fibroblast cell proliferation. By using single cell RNA sequencing, a subcluster of interferon-sensitive macrophages (IFNSMs) were identified after hucMSC infusion. These IFNSMs elevate the secretion of CXCL9 and CXCL10 following hucMSC infusion and recruit more Treg cells to the injured lung. CONCLUSIONS: Our study establishes a link between hucMSCs, macrophage, Treg, and PF. It provides new insights into how hucMSCs interact with macrophage during the repair process of bleomycin-induced PF and play its immunoregulation function.
BACKGROUND:Pulmonary fibrosis (PF) is a growing clinical problem with limited therapeutic options. Human umbilical cord mesenchymal stromal cell (hucMSC) therapy is being investigated in clinical trials for the treatment of PF patients. However, little is known about the underlying molecular and cellular mechanisms of hucMSC therapy on PF. In this study, the molecular and cellular behavior of hucMSC was investigated in a bleomycin-induced mouse PF model. METHODS: The effect of hucMSCs on mouse lung regeneration was determined by detecting Ki67 expression and EdU incorporation in alveolar type 2 (AT2) and lung fibroblast cells. hucMSCs were transfected to express the membrane localized GFP before transplant into the mouse lung. The cellular behavior of hucMSCs in mouse lung was tracked by GFP staining. Single cell RNA sequencing was performed to investigate the effects of hucMSCs on gene expression profiles of macrophages after bleomycin treatment. RESULTS: hucMSCs could alleviate collagen accumulation in lung and decrease the mortality of mouse induced by bleomycin. hucMSC transplantation promoted AT2 cell proliferation and inhibited lung fibroblast cell proliferation. By using single cell RNA sequencing, a subcluster of interferon-sensitive macrophages (IFNSMs) were identified after hucMSC infusion. These IFNSMs elevate the secretion of CXCL9 and CXCL10 following hucMSC infusion and recruit more Treg cells to the injured lung. CONCLUSIONS: Our study establishes a link between hucMSCs, macrophage, Treg, and PF. It provides new insights into how hucMSCs interact with macrophage during the repair process of bleomycin-induced PF and play its immunoregulation function.
Authors: Christina E Barkauskas; Michael J Cronce; Craig R Rackley; Emily J Bowie; Douglas R Keene; Barry R Stripp; Scott H Randell; Paul W Noble; Brigid L M Hogan Journal: J Clin Invest Date: 2013-06-10 Impact factor: 14.808
Authors: Kamran Atabai; Sina Jame; Nabil Azhar; Alex Kuo; Michael Lam; William McKleroy; Greg Dehart; Salman Rahman; Dee Dee Xia; Andrew C Melton; Paul Wolters; Claire L Emson; Scott M Turner; Zena Werb; Dean Sheppard Journal: J Clin Invest Date: 2009-11-02 Impact factor: 14.808
Authors: Antonio Galleu; Yanira Riffo-Vasquez; Cristina Trento; Cara Lomas; Luigi Dolcetti; Tik Shing Cheung; Malte von Bonin; Laura Barbieri; Krishma Halai; Sophie Ward; Ling Weng; Ronjon Chakraverty; Giovanna Lombardi; Fiona M Watt; Kim Orchard; David I Marks; Jane Apperley; Martin Bornhauser; Henning Walczak; Clare Bennett; Francesco Dazzi Journal: Sci Transl Med Date: 2017-11-15 Impact factor: 17.956